Tissue Regenix Group PLC
LSE:TRX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ten Entertainment Group PLC
LSE:TEG
|
UK |
|
S
|
Sygnity SA
WSE:SGN
|
PL |
|
D
|
Dom Development SA
WSE:DOM
|
PL |
|
S
|
Steel Exchange India Ltd
NSE:STEELXIND
|
IN |
|
DXI Capital Corp
XTSX:DXI.H
|
CA |
|
Plaza Centers NV
LSE:PLAZ
|
NL |
|
Shandong Huifa Foodstuff Co Ltd
SSE:603536
|
CN |
|
GPT Group
ASX:GPT
|
AU |
|
U
|
UOL Group Ltd
OTC:UOLGF
|
SG |
|
S
|
Shree Ajit Pulp and Paper Ltd
BSE:538795
|
IN |
|
B
|
BVZ Holding AG
LSE:0QML
|
CH |
|
S
|
Shh Resources Holdings Bhd
KLSE:SHH
|
MY |
|
Nevada Zinc Corp
XTSX:NZN
|
CA |
|
H
|
Hexing Electrical Co Ltd
SSE:603556
|
CN |
|
USA Compression Partners LP
NYSE:USAC
|
US |
|
Polar Power Inc
NASDAQ:POLA
|
US |
|
O
|
Ormat Technologies Inc
F:HNM
|
US |
|
G
|
Grupo Empresas Navieras SA
SGO:NAVIERA
|
CL |
|
Realty Income Corp
NYSE:O
|
US |
|
K
|
Komputronik SA w restrukturyzacji
WSE:KOM
|
PL |
|
Guizhou Redstar Developing Co Ltd
SSE:600367
|
CN |
|
A
|
Allied Resources Inc
OTC:ALOD
|
US |
Tissue Regenix Group PLC
Research & Development
Tissue Regenix Group PLC
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Tissue Regenix Group PLC
LSE:TRX
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Research & Development
-$150.2m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-104%
|
CAGR 10-Years
N/A
|
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Research & Development
-£274.9m
|
CAGR 3-Years
-46%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
|
|
Compass Pathways PLC
NASDAQ:CMPS
|
Research & Development
-$119m
|
CAGR 3-Years
-39%
|
CAGR 5-Years
-57%
|
CAGR 10-Years
N/A
|
|
|
Genus PLC
LSE:GNS
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Oxford BioMedica PLC
LSE:OXB
|
Research & Development
£9.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Tissue Regenix Group PLC
Glance View
Tissue Regenix Group Plc is a medical technology company, which develops and commercializes platform technologies in the field of tissue engineering and regenerative medicine. The company is headquartered in Leeds, West Yorkshire and currently employs 79 full-time employees. The company went IPO on 2006-12-21. The firm is focused on the development of regenerative products using its two platform technologies: decellularization (dCELL), which is used to produce allograft (DermaPure) and xenograft (OrthoPure XT) soft tissue products to promote healing and regeneration, and BioRinse, which is a natural bone filler solution verified to be osteoinductive to stimulate and regenerate native bone growth. The firm is engaged in transforming the treatment of patients in surgical applications, including BioSurgery, Orthopaedics (sports medicine/spine), Dental, General, Plastic Surgery, Urology/Gynaecology, Ophthalmology and Cardiac.
